Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration

por Packnett, Elizabeth R., Winer, Isabelle H., Oladapo, Abiola, Wojdyla, Matthew
Publicado 2023

1413. Trends in Risk of Respiratory Syncytial Virus Hospitalizations in Preterm Infants Over a 10-Year Period

por Kong, Amanda M, Winer, Isabelle H, diakun, david, Bloomfield, Adam, Gonzales, Tara
Publicado 2020

RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020

por Packnett, Elizabeth R., Winer, Isabelle H., Larkin, Heather, Oladapo, Abiola, Gonzales, Tara, Wojdyla, Matthew, Goldstein, Mitchell, Smith, Vincent C.
Publicado 2022

Increasing Rates of RSV Hospitalization among Preterm Infants: A Decade of Data

por Kong, Amanda M., Winer, Isabelle H., Zimmerman, Nicole M., Diakun, David, Bloomfield, Adam, Gonzales, Tara, Fergie, Jaime, Goldstein, Mitchell, Krilov, Leonard R.
Publicado 2021